SFM
Sphera Funds Management’s Corvus Pharmaceuticals CRVS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $732K | Sell |
183,094
-22,765
| -11% | -$91.1K | 0.17% | 86 |
|
2025
Q1 | $655K | Sell |
205,859
-294,632
| -59% | -$937K | 0.15% | 96 |
|
2024
Q4 | $2.68M | Buy |
+500,491
| New | +$2.68M | 0.48% | 66 |
|
2019
Q2 | – | Sell |
-83,607
| Closed | -$336K | – | 89 |
|
2019
Q1 | $336K | Sell |
83,607
-237,823
| -74% | -$956K | 0.03% | 95 |
|
2018
Q4 | $1.18M | Hold |
321,430
| – | – | 0.13% | 86 |
|
2018
Q3 | $2.76M | Sell |
321,430
-14,557
| -4% | -$125K | 0.32% | 77 |
|
2018
Q2 | $3.69M | Buy |
335,987
+14,557
| +5% | +$160K | 0.51% | 57 |
|
2018
Q1 | $3.71M | Buy |
321,430
+100,000
| +45% | +$1.15M | 0.56% | 49 |
|
2017
Q4 | $2.29M | Hold |
221,430
| – | – | 0.27% | 81 |
|
2017
Q3 | $3.53M | Sell |
221,430
-36,235
| -14% | -$578K | 0.5% | 52 |
|
2017
Q2 | $3.12M | Sell |
257,665
-21,501
| -8% | -$260K | 0.53% | 49 |
|
2017
Q1 | $5.8M | Sell |
279,166
-41,063
| -13% | -$853K | 1.13% | 16 |
|
2016
Q4 | $4.58M | Sell |
320,229
-4,824
| -1% | -$69K | 1.16% | 16 |
|
2016
Q3 | $5.35M | Hold |
325,053
| – | – | 0.87% | 22 |
|
2016
Q2 | $4.58M | Buy |
325,053
+214,132
| +193% | +$3.02M | 1.19% | 20 |
|
2016
Q1 | $1.61M | Buy |
+110,921
| New | +$1.61M | 0.35% | 60 |
|